{
    "organizations": [],
    "uuid": "29a376c7ea7e44b1fd0d05f7dce77e9c681dd953",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/05/10/the-associated-press-halozyme-therapeutics-1q-earnings-snapshot.html",
    "ord_in_thread": 0,
    "title": "Halozyme Therapeutics: 1Q Earnings Snapshot",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SAN DIEGO (AP) _ Halozyme Therapeutics Inc. (HALO) on Thursday reported a loss of $27.5 million in its first quarter.\nOn a per-share basis, the San Diego-based company said it had a loss of 19 cents.\nThe results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.\nThe biopharmaceutical company posted revenue of $30.9 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $29.5 million.\nHalozyme Therapeutics expects full-year revenue in the range of $115 million to $125 million.\nHalozyme Therapeutics shares have declined slightly more than 1 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.97, a rise of 47 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO",
    "published": "2018-05-11T00:44:00.000+03:00",
    "crawled": "2018-05-11T00:14:59.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "san",
        "diego",
        "ap",
        "halozyme",
        "therapeutic",
        "halo",
        "thursday",
        "reported",
        "loss",
        "million",
        "first",
        "quarter",
        "basis",
        "san",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "exceeded",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "four",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "biopharmaceutical",
        "company",
        "posted",
        "revenue",
        "million",
        "period",
        "also",
        "exceeding",
        "street",
        "forecast",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "halozyme",
        "therapeutic",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "halozyme",
        "therapeutic",
        "share",
        "declined",
        "slightly",
        "percent",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "thursday",
        "share",
        "hit",
        "rise",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "halo",
        "http"
    ]
}